Submit a Revision

*your email :**
page name* : such as "Introduction", "Conclusion"..etc
<ol><li> <p> <a></a>Sedaghat AR, Siliciano RF, Wilke CO: <strong>Low-level HIV-1 replication and the dynamics of the resting CD4+ T cell reservoir for HIV-1 in the setting of HAART. </strong> </p> <p> <em>BMC Infect Dis</em> 2008, <strong>8</strong>(1)<strong>:</strong>2. </p> <p> </p> </li> <li> <p> <a></a>Crowe S, Zhu T, Muller WA: <strong>The contribution of monocyte infection and trafficking to viral persistence, and maintenance of the viral reservoir in HIV infection. </strong> </p> <p> <em>J Leukoc Biol</em> 2003, <strong>74</strong>(5)<strong>:</strong>635-641. </p> <p> </p> </li> <li> <p> <a></a>Dybul M, Daucher M, Jensen MA, Hallahan CW, Chun TW, Belson M, Hidalgo B, Nickle DC, Yoder C, Metcalf JA, Davey RT, Ehler L, Kress-Rock D, Nies-Kraske E, Liu S, Mullins JI, Fauci AS: <strong>Genetic characterization of rebounding human immunodeficiency virus type 1 in plasma during multiple interruptions of highly active antiretroviral therapy. </strong> </p> <p> <em>J Virol</em> 2003, <strong>77</strong>(5)<strong>:</strong>3229-3237. </p> <p> </p> </li> <li> <p> <a></a>Popovic M, Tenner-Racz K, Pelser C, Stellbrink HJ, van Lunzen J, Lewis G, Kalyanaraman VS, Gallo RC, Racz P: <strong>Persistence of HIV-1 structural proteins and glycoproteins in lymph nodes of patients under highly active antiretroviral therapy. </strong> </p> <p> <em>Proc Natl Acad Sci U S A</em> 2005, <strong>102</strong>(41)<strong>:</strong>14807-14812. </p> <p> </p> </li> <li> <p> <a></a>Bhoopat L, Rithaporn TS, Khunamornpong S, Bhoopat T, Taylor CR, Thorner PS: <strong>Cell reservoirs in lymph nodes infected with HIV-1 subtype E differ from subtype B: identification by combined in situ polymerase chain reaction and immunohistochemistry. </strong> </p> <p> <em>Mod Pathol</em> 2006, <strong>19</strong>(2)<strong>:</strong>255-263. </p> <p> </p> </li> <li> <p> <a></a>Siliciano JD, Lai J, Callender M, Pitt E, Zhang H, Margolick JB, Gallant JE, Cofrancesco J Jr., Moore RD, Gange SJ, Siliciano RF: <strong>Stability of the latent reservoir for HIV-1 in patients receiving valproic acid. </strong> </p> <p> <em>J Infect Dis</em> 2007, <strong>195</strong>(6)<strong>:</strong>833-836. </p> <p> </p> </li> <li> <p> <a></a>Brooks DG, Hamer DH, Arlen PA, Gao L, Bristol G, Kitchen CM, Berger EA, Zack JA: <strong>Molecular characterization, reactivation, and depletion of latent HIV. </strong> </p> <p> <em>Immunity</em> 2003, <strong>19</strong>(3)<strong>:</strong>413-423. </p> <p> </p> </li> <li> <p> <a></a>Aquaro S, Bagnarelli P, Guenci T, De Luca A, Clementi M, Balestra E, Calio R, Perno CF: <strong>Long-term survival and virus production in human primary macrophages infected by human immunodeficiency virus. </strong> </p> <p> <em>J Med Virol</em> 2002, <strong>68</strong>(4)<strong>:</strong>479-488. </p> <p> </p> </li> <li> <p> <a></a>Schmidtmayerova H, Nottet HS, Nuovo G, Raabe T, Flanagan CR, Dubrovsky L, Gendelman HE, Cerami A, Bukrinsky M, Sherry B: <strong>Human immunodeficiency virus type 1 infection alters chemokine beta peptide expression in human monocytes: implications for recruitment of leukocytes into brain and lymph nodes. </strong> </p> <p> <em>Proc Natl Acad Sci U S A</em> 1996, <strong>93</strong>(2)<strong>:</strong>700-704. </p> <p> </p> </li> <li> <p> <a></a>Meltzer MS, Skillman DR, Gomatos PJ, Kalter DC, Gendelman HE: <strong>Role of mononuclear phagocytes in the pathogenesis of human immunodeficiency virus infection. </strong> </p> <p> <em>Annu Rev Immunol</em> 1990, <strong>8</strong><strong>:</strong>169-194. </p> <p> </p> </li> <li> <p> <a></a>Gartner S, Markovits P, Markovitz DM, Kaplan MH, Gallo RC, Popovic M: <strong>The role of mononuclear phagocytes in HTLV-III/LAV infection. </strong> </p> <p> <em>Science</em> 1986, <strong>233</strong>(4760)<strong>:</strong>215-219. </p> <p> </p> </li> <li> <p> <a></a>Aquaro S, Calio R, Balzarini J, Bellocchi MC, Garaci E, Perno CF: <strong>Macrophages and HIV infection: therapeutical approaches toward this strategic virus reservoir. </strong> </p> <p> <em>Antiviral Res</em> 2002, <strong>55</strong>(2)<strong>:</strong>209-225. </p> <p> </p> </li> <li> <p> <a></a>Perno CF, Aquaro S, Rosenwirth B, Balestra E, Peichl P, Billich A, Villani N, Calio R: <strong>In vitro activity of inhibitors of late stages of the replication of HIV in chronically infected macrophages. </strong> </p> <p> <em>J Leukoc Biol</em> 1994, <strong>56</strong>(3)<strong>:</strong>381-386. </p> <p> </p> </li> <li> <p> <a></a>Zhang M, Li X, Pang X, Ding L, Wood O, Clouse K, Hewlett I, Dayton AI: <strong>Identification of a potential HIV-induced source of bystander-mediated apoptosis in T cells: upregulation of trail in primary human macrophages by HIV-1 tat. </strong> </p> <p> <em>J Biomed Sci</em> 2001, <strong>8</strong>(3)<strong>:</strong>290-296. </p> <p> </p> </li> <li> <p> <a></a>Zhang M, Drenkow J, Lankford CS, Frucht DM, Rabin RL, Gingeras TR, Venkateshan C, Schwartzkopff F, Clouse KA, Dayton AI: <strong>HIV regulation of the IL-7R: a viral mechanism for enhancing HIV-1 replication in human macrophages in vitro. </strong> </p> <p> <em>J Leukoc Biol</em> 2006, <strong>79</strong>(6)<strong>:</strong>1328-1338. </p> <p> </p> </li> <li> <p> <a></a>Khati M, James W, Gordon S: <strong>HIV-macrophage interactions at the cellular and molecular level. </strong> </p> <p> <em>Arch Immunol Ther Exp (Warsz)</em> 2001, <strong>49</strong>(5)<strong>:</strong>367-378. </p> <p> </p> </li> <li> <p> <a></a>Singh IN, Goody RJ, Dean C, Ahmad NM, Lutz SE, Knapp PE, Nath A, Hauser KF: <strong>Apoptotic death of striatal neurons induced by human immunodeficiency virus-1 Tat and gp120: Differential involvement of caspase-3 and endonuclease G. </strong> </p> <p> <em>J Neurovirol</em> 2004, <strong>10</strong>(3)<strong>:</strong>141-151. </p> <p> </p> </li> <li> <p> <a></a>Shi B, Raina J, Lorenzo A, Busciglio J, Gabuzda D: <strong>Neuronal apoptosis induced by HIV-1 Tat protein and TNF-alpha: potentiation of neurotoxicity mediated by oxidative stress and implications for HIV-1 dementia. </strong> </p> <p> <em>J Neurovirol</em> 1998, <strong>4</strong>(3)<strong>:</strong>281-290. </p> <p> </p> </li> <li> <p> <a></a>Mattson MP, Haughey NJ, Nath A: <strong>Cell death in HIV dementia. </strong> </p> <p> <em>Cell Death Differ</em> 2005, <strong>12 Suppl 1</strong><strong>:</strong>893-904. </p> <p> </p> </li> <li> <p> <a></a>Kruman, Nath A, Mattson MP: <strong>HIV-1 protein Tat induces apoptosis of hippocampal neurons by a mechanism involving caspase activation, calcium overload, and oxidative stress. </strong> </p> <p> <em>Exp Neurol</em> 1998, <strong>154</strong>(2)<strong>:</strong>276-288. </p> <p> </p> </li> <li> <p> <a></a>Chugh P, Bradel-Tretheway B, Monteiro-Filh CMR, Planelles V, Maggirwar SB, Dewhurst S, Kim B: <strong>Akt inhibitors as an HIV-1 infected macrophage-specific anti-viral therapy. </strong> </p> <p> <em>Retrovirology</em> 2008, <strong>5</strong>(1)<strong>:</strong>11. </p> <p> </p> </li> <li> <p> <a></a>Aquaro S, Muscoli C, Ranazzi A, Pollicita M, Granato T, Masuelli L, Modesti A, Perno CF, Mollace V: <strong>The contribution of peroxynitrite generation in HIV replication in human primary macrophages. </strong> </p> <p> <em>Retrovirology</em> 2007, <strong>4</strong><strong>:</strong>76. </p> <p> </p> </li> <li> <p> <a></a>Chugh P, Fan S, Planelles V, Maggirwar SB, Dewhurst S, Kim B: <strong>Infection of human immunodeficiency virus and intracellular viral Tat protein exert a pro-survival effect in a human microglial cell line. </strong> </p> <p> <em>J Mol Biol</em> 2007, <strong>366</strong>(1)<strong>:</strong>67-81. </p> <p> </p> </li> <li> <p> <a></a>Kan H, Xie Z, Finkel MS: <strong>HIV gp120 enhances NO production by cardiac myocytes through p38 MAP kinase-mediated NF-kappaB activation. </strong> </p> <p> <em>Am J Physiol Heart Circ Physiol</em> 2000, <strong>279</strong>(6)<strong>:</strong>H3138-43. </p> <p> </p> </li> <li> <p> <a></a>Polazzi E, Levi G, Minghetti L: <strong>Human immunodeficiency virus type 1 Tat protein stimulates inducible nitric oxide synthase expression and nitric oxide production in microglial cultures. </strong> </p> <p> <em>J Neuropathol Exp Neurol</em> 1999, <strong>58</strong>(8)<strong>:</strong>825-831. </p> <p> </p> </li> <li> <p> <a></a>Zhao ML, Kim MO, Morgello S, Lee SC: <strong>Expression of inducible nitric oxide synthase, interleukin-1 and caspase-1 in HIV-1 encephalitis. </strong> </p> <p> <em>J Neuroimmunol</em> 2001, <strong>115</strong>(1-2)<strong>:</strong>182-191. </p> <p> </p> </li> <li> <p> <a></a>Reynolds A, Laurie C, Mosley RL, Gendelman HE: <strong>Oxidative stress and the pathogenesis of neurodegenerative disorders. </strong> </p> <p> <em>Int Rev Neurobiol</em> 2007, <strong>82</strong><strong>:</strong>297-325. </p> <p> </p> </li> <li> <p> <a></a>Goujon C, Riviere L, Jarrosson-Wuilleme L, Bernaud J, Rigal D, Darlix JL, Cimarelli A: <strong>SIVSM/HIV-2 Vpx proteins promote retroviral escape from a proteasome-dependent restriction pathway present in human dendritic cells. </strong> </p> <p> <em>Retrovirology</em> 2007, <strong>4</strong><strong>:</strong>2. </p> <p> </p> </li> <li> <p> <a></a>Jacquot G, le Rouzic E, David A, Mazzolini J, Bouchet J, Bouaziz S, Niedergang F, Pancino G, Benichou S: <strong>Localization of HIV-1 Vpr to the nuclear envelope: Impact on Vpr functions and virus replication in macrophages. </strong> </p> <p> <em>Retrovirology</em> 2007, <strong>4</strong>(1)<strong>:</strong>84. </p> <p> </p> </li> <li> <p> <a></a>Palamara AT, Perno CF, Aquaro S, Bue MC, Dini L, Garaci E: <strong>Glutathione inhibits HIV replication by acting at late stages of the virus life cycle. </strong> </p> <p> <em>AIDS Res Hum Retroviruses</em> 1996, <strong>12</strong>(16)<strong>:</strong>1537-1541. </p> <p> </p> </li> <li> <p> <a></a>Garaci E, Aquaro S, Lapenta C, Amendola A, Spada M, Covaceuszach S, Perno CF, Belardelli F: <strong>Anti-nerve growth factor Ab abrogates macrophage-mediated HIV-1 infection and depletion of CD4+ T lymphocytes in hu-SCID mice. </strong> </p> <p> <em>Proc Natl Acad Sci U S A</em> 2003, <strong>100</strong>(15)<strong>:</strong>8927-8932. </p> <p> </p> </li> </ol>
Confirmation code: Enter the code exactly as it appears. All letters are case insensitive, there is no zero.